Literature DB >> 4113219

Cholinergic reversal of manic symptoms.

D S Janowsky, M K el-Yousef, J M Davis, B Hubbard, H J Sekerke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113219     DOI： 10.1016/s0140-6736(72)90956-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Authors:  Maura L Furey; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

2.  The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

Authors:  Maura L Furey
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

3.  Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.

Authors:  Maura L Furey; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2006-10

4.  The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.

Authors:  R L Rabenstein; B J Caldarone; M R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

5.  [Depressive effects of physostigmine].

Authors:  J Modestin; J Hunger; R B Schwartz
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-11-27

6.  On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice.

Authors:  S Maayani; Y Egozi; I Pinchasi; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

7.  The effects of lithium and physostigmine on rat brain acetylcholinesterase activity.

Authors:  L L Simpson
Journal:  Psychopharmacologia       Date:  1974

8.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

Review 9.  Human biomarkers of rapid antidepressant effects.

Authors:  Carlos A Zarate; Daniel C Mathews; Maura L Furey
Journal:  Biol Psychiatry       Date:  2013-01-29       Impact factor: 13.382

Review 10.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.